Alirocumab (anti-PCSK9) [CAS 1245916-14-6]
Partner: MedChemexpress LLC
| CAS No: | 1245916-14-6 |
| Applications: | Neuroscience-Neuromodulation |
| MW: | N/A |
| Formula: | N/A |
| SMILES: | [Alirocumab (anti-PCSK9)] |
| Purity: | 99.00 |
| Description: | Alirocumab (anti-PCSK9) is a human monoclonal antibody inhibiting proprotein convertase subtilisin/kexin type 9 (PCSK9). Alirocumab specifically binds PCSK9, a down regulator of liver low-density lipoprotein (LDL)-receptors, thereby increasing the ability of the liver to bind LDL-cholesterol (LDL-C) and reducing levels of LDL-C in blood. Alirocumab can be used for the research of hypercholesterolemia[1][2]. |
| Shipping Conditions: | Ship on dry ice |
| Usage: | Research Use Only |
Insight Biotechnology Ltd reserves the right to change pricing without notice
